Orbis Allan Gray’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Orbis Allan Gray's RYTM Position: Q3 2026 in Review
Orbis Allan Gray opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2026: 1,196,608 shares worth $114M. The stake represents 0.38% of the portfolio and ranks #55 among its holdings.
334 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Orbis Allan Gray held 1,196,608 shares of Rhythm Pharmaceuticals worth $114M as of Q3 2026.
- Rhythm Pharmaceuticals was a new Orbis Allan Gray position in Q3 2026.
- Rhythm Pharmaceuticals made up 0.38% of Orbis Allan Gray's portfolio in Q3 2026, its #55 holding.
- 334 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Orbis Allan Gray's 13F filing for Q3 2026, filed 16 Nov 2026.